NEOGENIX, LLC dba OGENIX
Source from NEOGENIX, LLC dba OGENIX
Continue with the assistant to clarify your requirements and draft an enquiry. You review the message and choose recipients before anything is sent.
About NEOGENIX, LLC dba OGENIX
Ogenix manufactures EPIFLO, an FDA-cleared topical oxygen therapy device designed for 24/7 chronic wound treatment. The 3-ounce portable system delivers continuous oxygen therapy to address diabetic foot ulcers, venous stasis ulcers, pressure injuries, surgical wounds, burns, and other non-healing chronic wounds. EPIFLO functions as an adjunct therapy…
Read full company overview
Ogenix manufactures EPIFLO, an FDA-cleared topical oxygen therapy device designed for 24/7 chronic wound treatment. The 3-ounce portable system delivers continuous oxygen therapy to address diabetic foot ulcers, venous stasis ulcers, pressure injuries, surgical wounds, burns, and other non-healing chronic wounds. EPIFLO functions as an adjunct therapy suitable for outpatient and ambulatory wound care settings, enabling clinicians and patients to integrate advanced oxygen-based wound healing into standard clinical management protocols.
Contact Information
Send an Enquiry
Need a structured price?
Submit an RFP to compare NEOGENIX, LLC dba OGENIX alongside up to 4 other vendors. Sealed responses, side-by-side at the deadline.
Submit an RFP